[ Current status and prospects of immunotherapy for castration-resistant prostate cancer ] . Surgery , radiation and chemotherapy are three major therapies for cancer . But now , hope is being gathered in immunotherapy as a treatment for fourth . Immunotherapy has been done than before , but they are non-specific immunotherapy . Those that have become hot topics are specific immunotherapies targeting certain molecules or antigens . In this chapter , current status and prospects of immunotherapy for castration-resistant prostate cancer ( CRPC ) are described . As concrete examples , Sipuleucel-T(Provenge) , GVAX , PROSTVAC-VF , DB06186 ( anti- P16410 mAb ) , anti- P18621 mAb and anti- Q04609 mAb are cited . As a result , it is not obtained results which therapy also satisfactory at present . Because of its uncertainties we are in the developmental stages of this therapy and improved outcomes might be achievable .